China Risun Group Limited (1907.HK)

HKD 2.84

(1.43%)

EBITDA Summary of China Risun Group Limited

China Risun Group Limited's latest annual EBITDA in 2023 was 4.1 Billion CNY , down -8.19% from previous year.
China Risun Group Limited's latest quarterly EBITDA in 2024 Q2 was 910.55 Million CNY , down 0.0% from previous quarter.
China Risun Group Limited reported an annual EBITDA of 4.62 Billion CNY in 2022, down -20.8% from previous year.
China Risun Group Limited reported an annual EBITDA of 5.45 Billion CNY in 2021, up 72.72% from previous year.
China Risun Group Limited reported a quarterly EBITDA of 910.55 Million CNY for 2024 Q2, down 0.0% from previous quarter.
China Risun Group Limited reported a quarterly EBITDA of 718.06 Million CNY for 2023 Q1, up 42.34% from previous quarter.

Annual EBITDA Chart of China Risun Group Limited (2023 - 2015)

Historical Annual EBITDA of China Risun Group Limited (2023 - 2015)

Year	EBITDA	EBITDA Growth
2023	4.1 Billion CNY	-8.19%
2022	4.62 Billion CNY	-20.8%
2021	5.45 Billion CNY	72.72%
2020	3.22 Billion CNY	20.44%
2019	2.19 Billion CNY	-25.61%
2018	3.1 Billion CNY	77.37%
2017	1.56 Billion CNY	67.62%
2016	1.01 Billion CNY	372.2%
2015	310.35 Million CNY	0.0%

Year	EBITDA	EBITDA Growth
2024 Q1	910.55 Million CNY	-15.21%
2024 Q2	910.55 Million CNY	0.0%
2023 Q1	718.06 Million CNY	42.34%
2023 FY	- CNY	-8.19%
2023 Q4	1.07 Billion CNY	0.0%
2023 Q3	1.07 Billion CNY	49.56%
2023 Q2	718.06 Million CNY	0.0%
2022 Q1	1.43 Billion CNY	48.62%
2022 Q4	504.46 Million CNY	0.0%
2022 FY	- CNY	-20.8%
2022 Q3	504.46 Million CNY	-64.93%
2022 Q2	1.43 Billion CNY	0.0%
2021 Q2	1.5 Billion CNY	0.0%
2021 FY	- CNY	72.72%
2021 Q1	1.5 Billion CNY	68.17%
2021 Q3	967.75 Million CNY	-35.54%
2021 Q4	967.75 Million CNY	0.0%
2020 FY	- CNY	20.44%
2020 Q4	892.76 Million CNY	0.0%
2020 Q3	892.76 Million CNY	86.37%
2020 Q2	479.03 Million CNY	0.0%
2020 Q1	479.03 Million CNY	11.02%
2019 Q2	664.97 Million CNY	0.0%
2019 FY	- CNY	-25.61%
2019 Q1	664.97 Million CNY	-34.74%
2019 Q4	431.48 Million CNY	0.0%
2019 Q3	431.48 Million CNY	-35.11%
2018 Q1	590.61 Million CNY	31.6%
2018 Q2	590.61 Million CNY	0.0%
2018 Q3	1.01 Billion CNY	72.37%
2018 Q4	1.01 Billion CNY	0.1%
2018 FY	- CNY	77.37%
2017 Q4	448.79 Million CNY	0.0%
2017 FY	- CNY	67.62%
2016 FY	- CNY	372.2%
2015 FY	- CNY	0.0%

Peer EBITDA Comparison of China Risun Group Limited

Name	EBITDA	EBITDA Difference
Wai Chun Bio-Technology Limited	14.89 Million HKD	-27481.81%
Lee & Man Chemical Company Limited	597.01 Million HKD	-588.047%